Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALISERTIB for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where ALISERTIB was used for Neoplasm.

Most Reported Side Effects for ALISERTIB

Side Effect Reports % Deaths Hosp.
Neutropenia 16 19.1% 2 1
Dehydration 12 14.3% 1 4
Hyponatraemia 10 11.9% 0 2
Malignant neoplasm progression 10 11.9% 1 0
Toxicity to various agents 10 11.9% 0 0
Anaemia 9 10.7% 3 2
Leukopenia 9 10.7% 0 1
Lymphopenia 9 10.7% 0 2
Mucosal inflammation 9 10.7% 0 2
Febrile neutropenia 8 9.5% 1 2
Fatigue 7 8.3% 2 3
Vomiting 7 8.3% 1 1
Diarrhoea 6 7.1% 1 1
Thrombocytopenia 6 7.1% 2 1
Drug ineffective 5 6.0% 0 0

Other Indications for ALISERTIB

Neuroblastoma (14) Pancreatic carcinoma (11) Atypical teratoid/rhabdoid tumour of cns (7) Neoplasm malignant (6)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

ALISERTIB Full Profile All Neoplasm Drugs ALISERTIB Demographics ALISERTIB Timeline